Skip to main content

Table 1 Correlation between KAI1 and vimentin and E-cad expression to clinicopathological characteristics in 312 NSCLC patients

From: Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer

Variable

KAI1

P value

E-cadherin

P value

Vimentin

P value

(−)

(+)

(−)

(+)

(−)

(+)

Ages

  

0.622

  

0.894

  

0.336

 <60

95

52

 

88

59

 

89

58

 

 ≥60

111

54

 

100

65

 

91

74

 

Gender

  

0.038

  

0.423

  

0.597

 Male

147

87

 

138

96

 

137

97

 

 Female

59

19

 

50

28

 

43

35

 

Diameter

  

0.081

  

0.070

  

0.368

 <3.0 cm

32

9

 

30

11

 

21

20

 

 ≥3.0 cm

174

97

 

158

113

 

159

112

 

Histology

  

0.283

  

0.077

  

0.323

 SCC

155

79

 

144

90

 

137

97

 

 Adenocarcinoma

43

26

 

36

33

 

40

29

 

 LCC

8

1

 

8

1

 

3

6

 

Smoking

  

0.957

  

0.791

  

0.185

 Yes

151

78

 

139

90

 

127

102

 

 No

55

28

 

49

34

 

53

30

 

Grades of tumor

  

<0.001

  

<0.001

  

0.002

 Well

10

31

 

13

28

 

32

9

 

 Moderately

135

68

 

116

87

 

118

85

 

 Poorly

61

7

 

59

9

 

30

38

 

TNM stages

  

<0.001

  

<0.001

  

<0.001

 I

10

57

 

7

60

 

65

2

 

 II

85

35

 

77

43

 

89

31

 

 III

111

14

 

104

21

 

26

99

 

 VI

  

<0.001

  

<0.001

  

<0.001

 Yes

42

1

 

40

3

 

5

38

 

 No

164

105

 

148

121

 

175

94

 

Marginal free

  

0.119

  

0.085

  

<0.001

 Yes

171

95

 

155

111

 

167

99

 

 No

35

11

 

33

13

 

13

33

 
  1. NSCLC non-small cell lung cancer, SCC squamous cell carcinoma, LCC large cell carcinoma, VI vascular invasion